Ligand Pharmaceuticals Incorporated (LGND) — Long-term Investment Intensity
Ligand Pharmaceuticals Incorporated (LGND) has a Long-term Investment Intensity of 23.4% as of December 2025. Long-term investments of $364.83 Million represent 23.4% of total assets of $1.56 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See LGND net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ligand Pharmaceuticals Incorporated Long-term Investment Intensity (2012–2025)
This chart shows how Ligand Pharmaceuticals Incorporated's Long-term Investment Intensity has evolved across 9 annual periods from 2012 to 2025. As of December 2025, the intensity stands at 23.4%, reflecting long-term investments of $364.83 Million against total assets of $1.56 Billion USD. Also explore Ligand Pharmaceuticals Incorporated total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Ligand Pharmaceuticals Incorporated (2012–2025)
The table below presents the year-by-year Long-term Investment Intensity for Ligand Pharmaceuticals Incorporated from 2012 to 2025, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Ligand Pharmaceuticals Incorporated (LGND) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 23.4% | $364.83 Million | $1.56 Billion | ▲ +2.6 pp |
| 2024 | 20.8% | $195.93 Million | $941.77 Million | ▲ +14.7 pp |
| 2023 | 6.1% | $48.32 Million | $787.22 Million | ▲ +5.7 pp |
| 2022 | 0.4% | $3.00 Million | $762.67 Million | ▼ -0.6 pp |
| 2017 | 1.0% | $6.44 Million | $671.02 Million | ▼ -0.4 pp |
| 2016 | 1.4% | $8.35 Million | $601.59 Million | ▼ -4.2 pp |
| 2015 | 5.6% | $29.73 Million | $533.93 Million | ▲ +2.7 pp |
| 2014 | 2.9% | $7.42 Million | $258.03 Million | ▼ -5.0 pp |
| 2012 | 7.9% | $8.21 Million | $104.26 Million | — |